The aim of this review was to identify in a systematic manner the studies that reported risk factors associated with the presence of anaemia in patients with CKD and studies that characterised the association between anaemia (Hb level) and outcomes in patients with CKD. The gene discussed is GSTM1; the disease is chronic kidney disease.